title: Prostanoid imbalance in experimental acute necrotizing pancreatitis in rats.
abstract: In an investigation of the pathogenesis of acute necrotizing pancreatitis (ANP) the plasma levels of TXB2, 6-keto-PGF1 alpha, and PGE2 were measured in rats. After induction of ANP by injection of 5% sodium taurocholate into the pancreatic duct, a marked increase in TXB2 levels and a slight increase in 6-keto-PGF 1 alpha levels were found. PGE2 levels decreased. Mortality was 100% within 30 h. Pretreatment with chloroquine, a phospholipase A2 inhibitor, led to a inhibition of TXB2 production, whereas 6-keto-PGF1 alpha and PGE2 levels showed a surprising slight elevation in the first 6 h. Pretreatment with chloroquine decreased mortality by 30%. Pretreatment with FPL 55712, a leukotriene synthesis blocker, caused an increase in TXB2 and PGE2 levels, whereas the formation of 6-keto-PGF1 alpha remained unaltered. Two out of nine animals survived after pretreatment with FPL 55712. The results of the present study indicate that arachidonate end products are involved in ANP. The significance of the high TXB2 levels, decreased PGE2 levels, and only slightly elevated 6-keto-PGF1 alpha levels during ANP requires further investigation. The thromboxane A2 to prostacyclin ratio may be important.
authors.affiliation: Dept. of Experimental Surgery, Faculty of Medicine, Erasmus University Rotterdam, The Netherlands.
authors.forename: B
authors.initials: B
authors.lastname: van Ooijen
authors.forename: W J
authors.initials: WJ
authors.lastname: Kort
authors.forename: F J
authors.initials: FJ
authors.lastname: Zijlstra
authors.forename: J E
authors.initials: JE
authors.lastname: Vincent
authors.forename: J H
authors.initials: JH
authors.lastname: Wilson
authors.forename: D L
authors.initials: DL
authors.lastname: Westbroek
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000208:Acute Disease; D000818:Animals; D002738:Chloroquine / Q000008:administration & dosage; D002867:Chromones / Q000008:administration & dosage; D015232:Dinoprostone; D008297:Male; D009336:Necrosis; D010195:Pancreatitis / Q000097:blood* / Q000188:drug therapy; D011453:Prostaglandins / Q000097:blood*; D011458:Prostaglandins E / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D002867:Chromones; D011453:Prostaglandins; D011458:Prostaglandins E; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D002738:Chloroquine; C006312:FPL 55712; D015232:Dinoprostone